IL17A and chronic obstructive pulmonary disease: Western blot and RT-qPCR revealed that HPMHD inhibited the level of IL17 and led to a decrease in the level of downstream signals Cebpb and TN-ɑ, further confirmed that COPD could be treated by modulating the IL-17 signaling pathway.